Significant Accounting Policies - Statements of Financial Condition (Details) - USD ($) |
Mar. 31, 2026 |
Dec. 31, 2025 |
||
|---|---|---|---|---|
| Assets [Abstract] | ||||
| Due from affiliates | [1] | $ 7,628,285 | $ 15,613,554 | |
| Total assets | 990,476,336 | 1,701,201,529 | ||
| Liabilities and Equity [Abstract] | ||||
| Performance fee distributions payable | [1] | 10,654,945 | 54,838,527 | |
| Total liabilities | 105,998,320 | 622,088,641 | ||
| Non-controlling interest | [1] | 46,090,546 | 62,694,884 | |
| Total liabilities and partners' capital | 990,476,336 | 1,701,201,529 | ||
| Pershing Square GP, LLC | ||||
| Assets [Abstract] | ||||
| Due from affiliates | 5,660,559 | 11,800,000 | ||
| Total assets | 60,330,361 | 91,088,239 | ||
| Liabilities and Equity [Abstract] | ||||
| Accrued compensation and benefits | 8,579,256 | 16,593,355 | ||
| Performance fee distributions payable | 5,660,559 | 11,800,000 | ||
| Total liabilities | 14,239,815 | 28,393,355 | ||
| Non-controlling interest | 46,090,546 | 62,694,884 | ||
| Total liabilities and partners' capital | 60,330,361 | 91,088,239 | ||
| Pershing Square GP, LLC | Pershing Square, L.P. | ||||
| Assets [Abstract] | ||||
| Investment in Pershing Square, L.P., at fair value | 54,669,802 | 79,288,239 | ||
| Due from affiliates | $ 5,660,559 | $ 11,800,000 | ||
| ||||
| X | ||||||||||
- Definition Due from affiliate. No definition available.
|
| X | ||||||||||
- Definition Performance fee distributions payable. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total of all Partners' Capital (deficit) items which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|